Theriva Biologics Inc (TOVX)

[Inoviorulez]

I told people yesterday something was fishy about the way they released the results. Today they showed more and thus the reason for the drop. Basically the P value p = .0306 was significant at 12 months but at the primary endpoint for FDA approval was not met. Primary endpoint needed to be at p <= .05 but instead at 24 months it was p = .1537. Company now believes it can lower the p value from .1537 all the way down to .05 or less by adding more patients in the study. it may or may not be possible but the bottom line is that the primary endpoint was not met thus the reason for the drop. Company should have not put out positive preliminary results should have been more honest with its shareholders IMO.